Skip to content
OpenCapital
Get started

Celcuity CELC Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net

Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net at other companies

BridgeBio Pharma logo
BridgeBio PharmaBBIO
——
Tenet Healthcare logo
Tenet HealthcareTHC
——

Other financials

Income statement

See full
Operating income-$50.5M-39.8%
Net income-$52.8M-42.8%
EPS (diluted)-$0.97-12.8%

Balance sheet

See full
Cash & equivalents$145.2M+781%
Total debt$137.9M+30.7%
Total equity$53.5M-38.2%
Total assets$410.2M+88.0%

Cash flow

See full
Operating cash flow-$55.1M-53.6%
CapEx$249.0K+315%
Free cash flow-$55.3M-54.0%

Valuation

See full
Market cap$4.4B+1,370%

Returns & leverage

See full
Return on equity-275.2%-990pp
Debt / equity2.6×+1.4×
Current ratio12.3×+5.7×

Where this comes from

Reported directly by Celcuity in its filing.

Tagged under the XBRL concept us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet.

The official record: Celcuity’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Celcuity's debt instrument, unamortized discount (premium) and debt issuance costs, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Celcuity's debt instrument, unamortized discount (premium) and debt issuance costs, net?
Celcuity (CELC) reported debt instrument, unamortized discount (premium) and debt issuance costs, net of $2.09M in Q1 2026.
How has Celcuity's debt instrument, unamortized discount (premium) and debt issuance costs, net changed year-over-year?
Celcuity's debt instrument, unamortized discount (premium) and debt issuance costs, net increased by 52.4% year-over-year, from $1.37M to $2.09M.
What is the long-term trend for Celcuity's debt instrument, unamortized discount (premium) and debt issuance costs, net?
Over 4 years (2021 to 2025), Celcuity's debt instrument, unamortized discount (premium) and debt issuance costs, net has grown at a 61.3% compound annual growth rate (CAGR), from $386.58K to $2.62M.